681 related articles for article (PubMed ID: 20588135)
21. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
22. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
23. Acute decompensated heart failure and the cardiorenal syndrome.
Liang KV; Williams AW; Greene EL; Redfield MM
Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
[TBL] [Abstract][Full Text] [Related]
24. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion.
Ali SS; Olinger CC; Sobotka PA; Dahle TG; Bunte MC; Blake D; Boyle AJ
Congest Heart Fail; 2009; 15(1):1-4. PubMed ID: 19187399
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
26. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
Goldsmith SR
Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
[TBL] [Abstract][Full Text] [Related]
27. Approaches to diuretic therapy and electrolyte imbalance in congestive heart failure.
Cody RJ; Pickworth KK
Cardiol Clin; 1994 Feb; 12(1):37-50. PubMed ID: 8181024
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
29. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
30. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
31. [Continuous infusion versus bolus injection of loop diuretics in acute heart failure: a literature review].
Leto L; Aspromonte N; Feola M
G Ital Cardiol (Rome); 2012 Apr; 13(4):263-72. PubMed ID: 22495643
[TBL] [Abstract][Full Text] [Related]
32. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Peacock WF; Costanzo MR; De Marco T; Lopatin M; Wynne J; Mills RM; Emerman CL;
Cardiology; 2009; 113(1):12-9. PubMed ID: 18931492
[TBL] [Abstract][Full Text] [Related]
33. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
[TBL] [Abstract][Full Text] [Related]
34. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
[TBL] [Abstract][Full Text] [Related]
35. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
De Vecchis R; Baldi C; Di Biase G
Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
Sun WY; Reiser IW; Chou SY
Am J Kidney Dis; 2006 May; 47(5):798-808. PubMed ID: 16632018
[TBL] [Abstract][Full Text] [Related]
37. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Martin FL; Chen HH; Cataliotti A; Burnett JC
Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
[TBL] [Abstract][Full Text] [Related]
38. [Changes in renal function in heart failure and their modification by conversion enzyme inhibitors].
Heidland A; Teschner M; Götz R
Klin Wochenschr; 1991; 69 Suppl 24():65-72; discussion 72-4. PubMed ID: 1865635
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
40. Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future.
Taylor SH
Z Kardiol; 1985; 74 Suppl 2():2-12. PubMed ID: 3890392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
